Search results for "MIP"

showing 10 items of 623 documents

Neuropsychologic phenotypes in familial hemiplegic migraine

2003

Familial hemiplegic migraine (FHM) is a rare autosomal dominant-type migraine with aura. Attacks are characterised by hemiparesis in addition to other aura and migraine symptoms. Few studies have examined the influence of FHM on cognitive functions. This study was aimed to investigate neuropsychological functions in 3 adolescent siblings suffering from FHM assessed six months after the last attack. No relevant deficits were found on a battery of multisectorial tests exploring cognitive functions. Sporadic FHM attack therefore seems not to affect cognition in these patients, at least far from the crises.

Pediatricsmedicine.medical_specialtyAurabusiness.industryOriginalNeuropsychologyCognitionGeneral MedicineNeurological disordermedicine.diseaseKey words Familial hemiplegic migraineMigraine with auraDevelopmental psychologyCognitive functionsAnesthesiology and Pain MedicineMigraineNeuropsychologiamedicineNeuropsychologic phenotypesNeurology (clinical)medicine.symptombusinessFamilial hemiplegic migraineThe Journal of Headache and Pain
researchProduct

Long-term follow-up and novel genotype-phenotype analysis of monozygotic twins with ATP1A3 mutation in Alternating Hemiplegia of Childhood-2

2020

Alternating Hemiplegia of Childhood (AHC) is a rare disorder characterized by frequent, transient attacks of hemiplegia involving either side of the body or both in association to several other disturbances including dystonic spells, abnormal ocular movements, autonomic manifestations, epileptic seizures and cognitive impairment. The clinical manifestations usually start before the age of 18 months. Two forms of the disorder known as AHC-1 (MIM#104290) and AHC-2 (MIM#614820) depends on mutations in ATP1A2 and ATP1A3 genes respectively, with over 75% of AHC caused by a mutation in the ATP1A3 gene. Herewith, we report serial clinical follow-up data of monozygotic (MZ) twin sisters, who presen…

Pediatricsmedicine.medical_specialtyGenotype-phenotype correlationGenotypeTwinsHemiplegiaMonozygoticEpilepsyYoung AdultSettore MED/38 - Pediatria Generale E SpecialisticaATP1A2Alternating Hemiplegia of Childhood (AHC)ATP1A3GenotypeGeneticsmedicineHumansYoung adultATPase Na+/K+ transporting subunit alpha 2 (ATP1A2)Genetics (clinical)DystoniaATPase Na+/K+ transporting subunit alpha 3 (ATP1A3)business.industryAlternating hemiplegia of childhoodp.Asn773SerGeneral MedicineTwins Monozygoticmedicine.diseasePhenotypePhenotypeMutationFemaleSodium-Potassium-Exchanging ATPasebusiness
researchProduct

Benign nocturnal alternating hemiplegia of childhood: a new case with unusual findings

2014

Abstract It has been described a neuro developmental disorder labelled “Benign nocturnal alternating hemiplegia of childhood” (BNAHC) characterized by recurrent attacks of nocturnal hemiplegia without progression to neurological or intellectual impairment. We report a female patient who at 11 months revealed a motionless left arm, unusual crying without impairment of consciousness and obvious precipitating factors. The attacks occur during sleep in the early morning with lack of ictal and interictal electroencephalographic abnormalities, progressive neurological deficit, and cognitive impairment. Unlike previous reports of BNAHC our patient come from a family with a history of both migraine…

Pediatricsmedicine.medical_specialtyHemiplegiaNocturnalHemiplegic migraineDiagnosis DifferentialDevelopmental NeuroscienceSettore M-PSI/08 - Psicologia ClinicamedicineHumansIctalFamilyBenign nocturnal alternating hemiplegia of childhood; Alternating hemiplegia of childhood; Hemiplegic migraine; Sleep disordersSettore M-PSI/02 - Psicobiologia E Psicologia FisiologicaCryingIntellectual impairmentAlternating hemiplegia of childhoodSleep disordersGeneral Medicinemedicine.diseaseSettore MED/39 - Neuropsichiatria InfantileDevelopmental disorderMigraineAlternating hemiplegia of childhoodChild PreschoolPediatrics Perinatology and Child HealthHemiplegic migrainePhysical therapyFemaleNeurology (clinical)medicine.symptomPsychologySleepBenign nocturnal alternating hemiplegia of childhood
researchProduct

Meropenem Permeation through the Outer Membrane of <i>Pseudomonas aeruginosa</i> Can Involve Pathways Other than the OprD Porin Channel

1996

The outer membrane protein (OMP) OprD is the major channel through which carbapenems permeate the outer membrane of Pseudomonas aeruginosa. In this study, we analyzed the OMP profiles of several P. aeruginosa clinical isolates showing diminished susceptibility to imipenem while remaining susceptible to meropenem. All these isolates lacked OprD or showed a reduced expression of this porin. Susceptibility to meropenem was thus independent of the level of OprD expression, indicating that the antimicrobial could be taken up via an alternative route. The level of expression of OprC (70 kD) was also unrelated to meropenem susceptibility. Nevertheless, OMPs OprF and OprE were expressed by all isol…

PharmacologyImipenembiologyPseudomonas aeruginosaGeneral Medicinebiochemical phenomena metabolism and nutritionbacterial infections and mycosesbiology.organism_classificationmedicine.disease_causeMeropenemPorinaMicrobiologyInfectious DiseasesOncologyDrug DiscoveryPorinpolycyclic compoundsmedicinebacteriaPharmacology (medical)Bacterial outer membranemedicine.drugPseudomonadaceaeAntibacterial agentChemotherapy
researchProduct

Psychotropic drug competition for [3H]imipramine binding further indicates the presence of only one high-affinity drug binding site on human α1-acid …

1983

PharmacologyPsychotropic DrugsChemistryCircular DichroismReceptors Drugmedia_common.quotation_subjectPharmaceutical ScienceOrosomucoidIn Vitro Techniques3h imipramine bindingPharmacologyBinding CompetitiveAntidepressive AgentsCompetition (biology)Receptors NeurotransmitterKineticsPsychotropic drugα1 acid glycoproteinDrug Binding SiteHumansCarrier ProteinsDialysisProtein Bindingmedia_commonJournal of Pharmacy and Pharmacology
researchProduct

ACE inhibitor potentiation of bradykinin-induced venoconstriction

1997

1. Angiotensin-converting enzyme (ACE) inhibitors exert their cardiovascular effects not only by preventing the formation of angiotensin II (AII), but also by promoting the accumulation of bradykinin in or at the vessel wall. In addition, certain ACE inhibitors have been shown to augment the vasodilator response to bradykinin, presumably by an interaction at the level of the B2 receptor. We have investigated whether this is a specific effect of the ACE inhibitor class of compounds in isolated endothelium-denuded segments of the rabbit jugular vein where bradykinin elicits a constrictor response which is exclusively mediated by activation of the B2 receptor. 2. Moexiprilat and ramiprilat (< …

PharmacologyRamiprilmedicine.medical_specialtybiologyEnalaprilatBradykininAngiotensin-converting enzymeCaptoprilchemistry.chemical_compoundEndocrinologychemistryInternal medicineACE inhibitorcardiovascular systemmedicinebiology.proteinBradykinin receptorRamiprilatmedicine.drugBritish Journal of Pharmacology
researchProduct

Characterization of a common binding site for basic drugs on human ?2-acid glycoprotein (orosomucoid)

1983

The interaction of chlorpromazine, dl-propranolol, and imipramine with isolated α1-acid glycoprotein is characterized by relatively high association constants and only one binding site per protein molecule. The mutual displacement between the three drugs indicates that all three compounds are bound to the same binding site. Several other basic drugs from different pharmacological and chemical classes also displace chlorpromazine, dl-propranolol, and imipramine with potencies, one would predict from their association constants or from the degree of their plasma binding in humans. It is concluded that displacement phenomena like those observed in this study in vitro are likely to occur also i…

Pharmacologychemistry.chemical_classificationbiologyChemistryOrosomucoidGeneral MedicineImipramineIn vitroBiochemistryIn vivomedicinebiology.proteinMoleculeBinding siteGlycoproteinChlorpromazinemedicine.drugNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

Dopamine autoreceptor agonists in the treatment of schizophrenic disorders

1993

Abstract 1. Synthesis and release of dopamine as well as firing rates of dopaminergic neurons are controlled by stimulation of autoreceptors via a negative feedback regulation, investigations on therapeutic effects of autoreceptor-nonselective dopamine agonists in schizophrenia have yielded inconsistent results. 2. With respect to the dopamine hypothesis of schizophrenia, dopamine autoreceptor agonists have been tested in positive schizophrenic symptomatology in order to reduce the postulated excess of central dopaminergic activity. However, administration of selective dopamine autoreceptor agonists like talipexole or roxindole did not result in a significant improvement of psychopathologic…

Pharmacologymedicine.medical_specialtyPramipexoleDopamine AgentsDopaminergicTalipexoleEndocrinologyDopamine receptorDopamine receptor D3DopamineInternal medicineDopamine receptor D2SchizophreniamedicineAutoreceptorHumansSchizophrenic PsychologyPsychologyBiological Psychiatrymedicine.drugClinical psychologyProgress in Neuro-Psychopharmacology and Biological Psychiatry
researchProduct

High-precision mass measurements for the rp-process at JYFLTRAP

2017

The double Penning trap JYFLTRAP at the University of Jyvaskyla has been successfully used to achieve high-precision mass measurements of nuclei involved in the rapid proton-capture (rp) process. A precise mass measurement of 31 Cl is essential to estimate the waiting point condition of 30 S in the rp-process occurring in type I x-ray bursts (XRBs). The mass-excess of 31 C1 measured at JYFLTRAP, -7034.7(3.4) keV, is 15 more precise than the value given in the Atomic Mass Evaluation 2012. The proton separation energy S p determined from the new mass-excess value confirmed that 30 S is a waiting point, with a lower-temperature limit of 0.44 GK. The mass of 52 Co effects both 51 Fe( p,γ ) 52 C…

PhysicsIon Traps (Instrumentation)protonitProtonta114protons010308 nuclear & particles physicsPhysicsQC1-999Analytical chemistryAntiprotonsrp-processPenning trapatomipainot01 natural sciencesMass measurementAtomic massnukleonitnucleons0103 physical sciencesmassamass010306 general physicsAtomic Weights
researchProduct

A molecular study of Neophyllaphis varicolor (Hemiptera, Aphididae) in Costa Rica

2019

The genus Neophyllaphis (Takahashi) (Aphididae: Neophyllaphidinae) is composed of 18 species; however, in the Americas only nine species have been reported previously. A new species, Neophyllaphis varicolor Miller & Halbert, was described in 2014 in USA. Colonies resembling those of this new species have been observed in Costa Rica on Podocarpus spp. In order to determine if N. varicolor is also present in Costa Rica, we sampled Neophyllaphis colonies from Podocarpus falcatus and P. chinensis. Additionally, we sampled individuals from Podocarpus sp. in Spain and Vietnam. DNA of each sample was extracted and used to amplify and sequence the cytochrome c oxidase subunit I (COI) and elongation…

PodocarpusInsectaArthropodaZoologyBiologyDNA barcodingPodocarpusHemipteraAphididaeGenuslcsh:ZoologyAnimaliaCytochrome c oxidase subunit IDNA barcodinglcsh:QL1-991integrative taxonomyEcology Evolution Behavior and SystematicsNeophyllaphidinaeElongation factor IPhylogenetic analysisPhylogenetic treephylogenetic analysisCytochrome c oxidase subunit IAphididaecytochrome c oxidase subunit Ibiology.organism_classificationHemipteraAphidsAphidoideaIntegrative taxonomyAnimal Science and Zoologyelongation factor IZooKeys
researchProduct